✦ LIBER ✦

Sclerostin and Dickkopf-1 as Therapeutic Targets in Bone Diseases

✍ Scribed by Ke, H. Z.; Richards, W. G.; Li, X.; Ominsky, M. S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dickkopf-1 as a mediator and novel targe

✍ Rachner, Tilman D.; Göbel, Andy; Benad-Mehner, Peggy; Hofbauer, Lorenz C.; Raune 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 925 KB

Dickkopf-1 and sclerostin in patients wi

✍ D. Cejka; D. Diarra; M. Födinger; B. Bohle; M. Haas 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Suppression of Sclerostin and Dickkopf-1

✍ Wang, Wenpeng; Xu, Jian; Liu, Kejian; Liu, Xiaoli; Li, Changcheng; Cui, Caiyan; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 464 KB

Circulating Sclerostin and Dickkopf-1 (D

✍ Thambiah, S.; Roplekar, R.; Manghat, P.; Fogelman, I.; Fraser, W. D.; Goldsmith, 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 212 KB

Dickkopf-1 is a key regulator of myeloma

✍ Zhou, Fuling; Meng, Shan; Song, Huanjin; Claret, François X. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 620 KB

Outpatient Management of Chronic Kidney

✍ Albert Lam; Siddharth Shah; James Paparello 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 331 KB